SCHEMBL24729296

SCHEMBL24729296

Cc1c(I)cc(-c2ccccc2)cc1-c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGS1 P23219 1/20 0.50
▸ HPRT1 P00492 1/20 0.42
▸ SQOR Q9Y6N5 1/20 0.41
▸ PTPN1 P18031 1/20 0.39
▸ ESR2 Q92731 1/20 0.38
▸ BACE1 P56817 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ PDCD1 Q15116 1/20 0.37
▸ CD274 Q9NZQ7 1/20 0.37
▸ CYP2A6 P11509 1/20 0.36
▸ CYP2B6 P20813 1/20 0.36
▸ HTT P42858 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ AKT1 P31749 1/20 0.34
▸ AKT2 P31751 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ APAF1 O14727 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20663065 0.84 PTGS1 (0.58) PTGS1HPRT1SQORPTPN1ESR2
SCHEMBL21172871 0.83 PDCD1 (0.44) PTGS1SQORESR2BACE1ALDH1A1
SCHEMBL5547337 0.78 PTGS1 (0.53) PTGS1HPRT1SQORPTPN1ESR2
SCHEMBL21917366 0.75 CRHBP (0.52) PTGS1HPRT1SQORPTPN1ESR2
SCHEMBL24839908 0.75 CRHBP (0.42) PTGS1HPRT1PTPN1BACE1ALDH1A1
SCHEMBL14682568 0.75 PTGS1 (0.50) PTGS1HPRT1SQORPTPN1ESR2
SCHEMBL28540513 0.75 PTGS1 (0.54) PTGS1HPRT1SQORPTPN1ESR2
SCHEMBL4971393 0.75 ALDH1A1 (0.47) PTGS1HPRT1PTPN1BACE1ALDH1A1
SCHEMBL24051152 0.74 PDCD1 (0.53) SQORESR2BACE1ALDH1A1PDCD1
SCHEMBL24656816 0.73 HPRT1 (0.53) HPRT1ALDH1A1HTTSMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11476429-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound SAMSUNG ELECTRONICS CO., LTD. (KR) 2022-10-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11476429-B2 Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound LEF1, ORC3, OCIAD1 PTGS1 2258/4885HPRT1 417/4885SQOR 352/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback